Published by
@ShahidNShah
@ShahidNShah
April 23 to April 25, 2024
The Westin Boston Seaport District, 425 Summer Street, Boston, Massachusetts, 02210, United States
Join the Exosome Characterization & Analytical Development Summit from April 23 to 25, 2024, as it delves into the dynamic exosome field's recent strides, including Kimera's FDA IND approval and Brexogen's collaboration with HK inno.N. With advancements in analytical technology shaping the landscape, this summit becomes pivotal in developing robust techniques. These techniques form the foundation for exosome therapeutics, drug delivery applications, and overall progress in the field. This comprehensive forum facilitates skill acquisition, aiding in the selection of optimal instruments, ensuring quality, and navigating regulatory processes seamlessly. Don't miss this opportunity to stay at the forefront of exosome research and development.
[Read on exosome-analytical-development.com](https://exosome-analytical-development.com/)
Continue reading at exosome-analytical-development.com
April 23 to April 25, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am